Financing
Proceeds From Issuance Of Senior Long Term Debt
Boston Scientific Proceeds From Issuance Of Senior Long Term Debt decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $1.56B to $0.00.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryLeverage
SignalContext dependent
VolatilityVolatile
First reportedQ1 2018
Last reportedQ1 2026May 1, 2026
How to read this metric
High proceeds indicate a need for capital, often for growth or refinancing existing obligations.
Detailed definition
Cash inflows generated from the issuance of senior debt securities to institutional or public markets. This is a primary...
Peer comparison
Standard for companies utilizing debt markets to manage their capital structure.
Metric ID:
financing_proceeds_from_issuance_of_senior_long_term_debtHistorical Data
11 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $3.27B | $0.00 | $0.00 | $0.00 | $0.00 | $2.15B | $1.56B | $0.00 |
| QoQ Change | — | — | — | — | -100.0% | — | — | — | — | -27.4% | -100.0% |
| YoY Change | — | — | — | — | -100.0% | — | — | — | — | -27.4% | -100.0% |
Range$0.00 – $3.27B
Avg YoY Growth-75.8%
Median YoY Growth-100.0%
Current Streak2+ quarters decline
Proceeds From Issuance Of Senior Long Term Debt at Other Companies
Frequently Asked Questions
- What is Boston Scientific's proceeds from issuance of senior long term debt?
- Boston Scientific (BSX) reported proceeds from issuance of senior long term debt of $0.00 in Q1 2026.
- How has Boston Scientific's proceeds from issuance of senior long term debt changed year-over-year?
- Boston Scientific's proceeds from issuance of senior long term debt decreased by 100.0% year-over-year, from $1.56B to $0.00.
- What does proceeds from issuance of senior long term debt mean?
- Cash received from issuing new long-term debt.